Evidence map›Paper›PMID 26221347›Full record

ArticleInternational journal of clinical and experimental medicine2015

Long-term prognosis and related factors towards patients with acute pulmonary thromboembolism.

Xiaowei Gong, Zheng Duan, Yadong Yuan

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Xiaowei GongDepartment of Respiratory Disease & Critical Care Medicine, The Second Hospital of Hebei Medical University Shijiazhuang 050000, China.
Zheng DuanDepartment of Respiratory Disease & Critical Care Medicine, The Second Hospital of Hebei Medical University Shijiazhuang 050000, China.
Yadong YuanDepartment of Respiratory Disease & Critical Care Medicine, The Second Hospital of Hebei Medical University Shijiazhuang 050000, China.
Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to investigate the long-term prognosis and the affecting factors towards the patients with acute pulmonary thromboembolism (APTE). The clinical data of 903 PTE patients, diagnosed by the spiral CT pulmonary angiography (CTPA) or lung ventilation perfusion scanning when hospitalized in the Second Hospital of Hebei Medical University from January 1998 to December 2013, were collected, among who 548 patients were performed the long-term follow-up, and the factors that would affect the prognosis were statistically analyzed. The univariate analysis showed that many factors would affect the prognosis of PTE. The multivariate non-conditional logistic regression analysis showed that: the relevant factors of re-embolization included the idiopathic pulmonary embolism, RVD, D-dimer positive, anticoagulation treatment < 3 months, post-treatment PASP > 40 mmHg, the relevant factors of death included the D-dimer positive, anticoagulation treatment < 3 months, cTnI positive, post-treatment PASP > 40 mmHg. RVD and post-treatment PASP > 40 mmHg would increase the risk of chronic thromboembolic pulmonary hypertension (CTEPH). The idiopathic pulmonary embolism, RVD, D-dimer positive, anticoagulation treatment < 3 months, cTnI positive and post-treatment PASP > 40 mmHg were the important factors that would affect the long-term prognosis of PTE patients.

Indexed as

prognosisPulmonary thromboembolismrisk factors

Identifiers

PMID26221347
PMCPMC4509292
OpenAlexW1424378267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.